Please login to the form below

Not currently logged in
Email:
Password:

board of directors

This page shows the latest board of directors news and features for those working in and with pharma, biotech and healthcare.

Purdue Pharma files for bankruptcy after opioid settlement

Purdue Pharma files for bankruptcy after opioid settlement

Other contributions include the formation of a new company called NewCo, which will be governed by a new board selected by the claimants and approved by the bankruptcy court. ... to cope with the opioid crisis,” said Steve Miller, chairman of

Latest news

  • Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

    Will join Pfizer board. Just 83 days after leaving his Commissioner role at the FDA, Scott Gottlieb has joined the board of big pharma group Pfizer. ... We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive

  • Amgen buys Danish partner Nuevolution for $167m Amgen buys Danish partner Nuevolution for $167m

    The board of Copenhagen-based, Sweden-listed Nuevolution has accepted a 32.5 Swedish krona per share offer from Amgen, which is a 169% premium on the company’s closing price ... The biotech’s board of directors has unanimously recommended the deal to

  • Blood disorder specialists Imara raises $63m Blood disorder specialists Imara raises $63m

    mechanism of targeting both red and white blood cells make the drug highly potent. ... In return, Arix owns 10% of the company and Investment Director Mark Chin will join Imara’s board of directors.

  • Novartis and Syncona back new Swiss biotech Anaveon Novartis and Syncona back new Swiss biotech Anaveon

    Andreas Katopodis. The company has also added a few new faces to its board of directors, including Florian Muellershausen from Novartis Venture Fund, which backed the series A financing round. ... Syncona is the venture funding group driving a lot of

  • Pfizer names next CEO as Read retires Pfizer names next CEO as Read retires

    The company’s board of directors unanimously elected Dr. Albert Bourla, Pfizer's current Chief Operating Officer (COO), to succeed Ian Read as CEO from 1 January, 2019. ... assets. Shantanu Narayen, Lead Independent Director of Pfizer’s Board of

More from news
Approximately 0 fully matching, plus 157 partially matching documents found.

Latest Intelligence

  • Charting a course for expansion Charting a course for expansion

    a key licensing agreement and the not inconsequential matter of a management reshuffle. ... In February deputy CEO Christel Bories was ousted, with the company highlighting disagreements over strategy between her and its board of directors.

  • Dispensing with the past Dispensing with the past

    The vast majority of board directors, nearly two-thirds (63%), have previous general management experience, and nearly half (48%) have previous or current CEO experience of a commercial, for-profit company. ... Current board composition at the top pharma

  • Tracking comms trends: 2 + 2 = 7: bad maths, or good sense? Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

    And it's true for people too. Whether it's a premier league football team or a FTSE 500 board of directors, what makes these high performing teams so successful is ... For both of these trends we are seeing pharma look outside its own walls – fresh,

  • Healthcare and the digital revolution Healthcare and the digital revolution

    Experience suggests that the key to securing a competitive advantage is to embrace digital as a solution from within the business, with effective governance at the board level and good internal ... Digital leadership from the board of directors sends out

  • The human perspective The human perspective

    Overseeing these strategic manoeuvres will be Hubertus von Baumbach, who takes over as chairman of the board of managing directors from Prof Andreas Barner on 1 July. ... Neumann was appointed to his present role, where he has responsibility for the

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

  • New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

    He initially joined Merus’ board of directors back in June 2019, bringing more than 15 years of experience managing and leading biotechnology research and development. ... Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney

  • New hires at Abbott, Kite and Arrakis Therapeutics New hires at Abbott, Kite and Arrakis Therapeutics

    We're confident he will continue Abbott's outstanding legacy of success," said William Osborn, lead director and chair of the Nominations and Governance Committee of Abbott’s Board of Directors. ... chairman of its Board of Directors. She has nearly 30

  • Industry appointments Industry appointments

    Meanwhile, as part of a board refreshment process, Allergan has also announced that Neurobiologist Michael Greenberg will join its board of directors. ... Following the retirement of Fred Weiss and the addition of Greenberg, Allergan's Board of Directors

  • Weekly industry appointments Weekly industry appointments

    Also joining the company is Boehringer Ingelheim USA’s ex chief executive Paul Fonteyne (pictured bottom right), who joins the group’s board of directors, bringing experience in commercial, marketing and ... Fonteyne’s history has also seen him sit

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    Francois Nader joins the biotech. Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition ... Nader said: “I am

More from appointments
Approximately 0 fully matching, plus 216 partially matching documents found.

Latest from PMHub

  • Internationally renowned doctors join the Havas Lynx team

    Alongside the new appointments, there have also been changes to the existing team, with Dr Vernon Bainton promoted to Chief Medical Officer and he will now join the Board of Directors. ... We’re privileged to have such an illustrious team of medical

  • Laura Brown appointed to Ashfield Meetings & Events’ board.

    Ashfield Meetings &Events, healthcare event management specialist, is delighted to announce the key appointment of Laura Brown to the board of directors as Senior Vice President of Operations. ... The appointment of a second board director in the US is

  • Blue Latitude boosts its team

    Blue Latitude has appointed Ben Routley, Natalie Seebeck and Kasia Zygadlewicz to its team, following a series of new business wins and increased work from existing clients. ... Meanwhile, Elisa del Galdo has been appointed to Blue Latitude's board of

  • Eric Hansen appointed MD at PAN

    I am delighted to announce Eric’s appointment as Managing Director of PAN,’ says Catherine. ... Eric will lead the PAN Board of Directors comprising Arron O’Hare, Creative Director; Julia Straker, Director of Strategic Brand Planning and Sarah

  • PAN promotes Julia Straker to Director of Strategic Brand Planning

    Julia Straker who joined PAN in June 2012 has been promoted to Director of Strategic Brand Planning and joins the agency’s board of directors. ... Previously a planner at TBWA/Paling Walters, Straker has become an integral member of the PAN team with a

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics